Health ❯ Healthcare

Regulatory Approval

FDA FDA Approval NHS Drug Approval Process European Medicines Agency European Commission Wegovy Approval Process FDA Approvals Drug Approval Medical Device Clearance Insurance Plans Xenotransplantation EU Regulations MHRA Drug Evaluation Health Authorities Product Development Health Canada Clinical Guidelines Drug Regulation Drug Controller General of India Medical Devices UK Healthcare System Drug Development Medicare Plans Semaglutide Tablet Clinical Trials NHS Treatments NICE Recommendations FDA Processes Clinical Stage Companies Wegovy® Pill NICE TGA Wegovy Pill

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

The company said it will seek U.S. approval by filing a Biologics License Application for Zenkuda in Q4 to pursue its first commercial product.

FDA Approves Fayuvi, Ultragenyx’s $3.95 Million One‑Time Gene Therapy for Sanfilippo A

NICE Recommends Once-Weekly Insulin Onswik for Adults With Type 2 Diabetes

Costco Partners With SCAN to Sell Co‑Branded Medicare Plans

EyePoint Stock Collapses After Duravyu Misses Phase 3 Primary Endpoint

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

EU Grants Conditional Approval for ImmunityBio’s Anktiva in BCG‑Unresponsive Bladder Cancer

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

FTC Files to Block Edwards Lifesciences’ $945 Million JenaValve Acquisition

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure